Artia Global Partners »

Tarsus Pharmaceuticals shares owned by Artia Global Partners

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.2M 21k 55.37

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Argenx Se Sponsored Adr (ARGX)
Soleno Therapeutics (SLNO)
Verona Pharma Sponsored Ads (VRNA)
Uniqure Nv SHS (QURE)
Merus N V (MRUS)
Proshares Tr Ii Ultra Gold (UGL)
Eli Lilly & Co. (LLY)
Vertex Pharmaceuticals Incorporated (VRTX)
Abivax Sa Sponsored Ads (ABVX)
Trevi Therapeutics (TRVI)
Boston Scientific Corporation (BSX)
Alnylam Pharmaceuticals (ALNY)
Quest Diagnostics Incorporated (DGX)
Astrazeneca Sponsored Adr (AZN)

View all positions for Artia Global Partners

Top funds holding Tarsus Pharmaceuticals

BlackRock
Rtw Investments
Deep Track Capital
Paradigm Biocapital Advisors
Jennison Associates
Tang Capital Management
Vanguard Group
Morgan Stanley
Henderson Group
Assenagon Asset Management
Frazier Life Sciences Management
Driehaus Capital Management
Lord, Abbett & Co
Geode Capital Management
Invesco

View all funds holding Tarsus Pharmaceuticals